HAE
HAEMONETICS CORP
Key Financials
Operating Income
$156.7M
↓ 29.3%
Net Income
$97.3M
↓ 42.0%
Revenue
$1.3B
↓ 2.0%
Gross Profit
$787.6M
↑ 5.2%
Total Assets
$2.4B
↓ 2.2%
Shareholders' Equity
$796.3M
↓ 3.0%
Cash & Equivalents
$245.4M
↓ 20.0%
EPS (Diluted)
$2.05
↓ 38.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 5/20/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| 4 | 5/19/2026 | View on SEC |
| SCHEDULE 13G/A | 5/13/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HAE |
| Company Name | HAEMONETICS CORP |
| CIK | 313143 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0328 |
| State of Incorporation | MA |
| Phone | 7818487100 |